Poll: What do you Think of "Female Viagra"?

Article

A Phase II trial is underway for Tefina, a testosterone-based treatment for female sexual dysfunction.

A Phase II trial is underway for Tefina, a testosterone-based treatment for female sexual dysfunction. Nicknamed “the female Viagra,” the drug is administered via a nasal spray two hours before sexual activity, and is believed to increase desire and stimulate blood flow to the sexual organs, making it appropriate for both women with low desire as well as women with difficulty climaxing.

One fertility specialist, Ric Gordon, said he believed that the drug was “exploiting” female sexuality, because it overlooked the reasons behind a low sexual drive. He maintained that “men use sex to de-stress and women need to be de-stressed to have sex,” and so by bringing this drug to market, more complicated emotional issues will be ignored


 

Online Poll

|

Online Survey

Please add your thoughts in the Comments section below.
 

Recent Videos
Fertility counseling for oncology patients | Image Credit: allhealthtv.com
Learning what women prefer in STI preventive care
Why doxycycline PEP lacks clinical data for STI prevention in women
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
Understanding the impact of STIs on young adults | Image Credit: providers.ucsd.edu.
How to address sexual dysfunction during menopause | Image Credit: health.usnews.com
Beth Garner, MD, MPH
Raising awareness on STDs
Related Content
© 2024 MJH Life Sciences

All rights reserved.